Application Notes

Cellastim S – Reconstitution Application Note

Optiferrin – Using rTransferrin in the Expansion of Hematopoietic Stem Cells Application Note

rHSA Reconstitution Video Protocol

Cell Culture Media & The Emergence of Blood-Free Components

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

ITSE+A – Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture Application Note

OptiPEAK HEK293t – Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media Application Note

OptiPEAK T-Lymphocyte Application Note

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Blog

3 Takeaways from the World Vaccine Congress 2018

ASGCT 2019: Remarkable Milestones and Achievements in Cell and Gene Therapy

BIO 2018: The Emergence of Gene & Cell Therapy

BIO Europe 2018: From Lab Innovations to Commercial Realities

BioInnovation on Parade: Philly Stands Proud for BIO 2019!

Cellastim S Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Controlling Impurities in Cell Culture Media

ECI Conference 2019: The Latest Innovations and Trends in Cell & Gene Therapy

Emergence of a Blood-Free rHSA

Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media

Expansion of T Cells without Serum in Chemically Defined Media

Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

Exploring the Latest Research and Opportunities in T-reg Therapy

Happy Holidays from the InVitria Team!

High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media

InVitria at the American Association of Immunologists 2018 Conference

InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area

InVitria: Solving the Vaccine Supply Challenge

InVitria’s Top Insights from ISCT 2018 – Montreal

Join InVitria at ECI 2019

Join InVitria at Phacilitate 2019

Phacilitate 2019 and World Stem Cell Summit

Recent Advances of Chemical Definition of Cell Culture Media and Excipients for Virus and Viral Vector Manufacturing

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Recombinant Human Leukemia Inhibitory Factor for the Enhanced Expansion of Neural Stem Cells

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

Reconstitution of Cellastim S for Cell-Culture Applications

Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture

SARS-CoV2 and Influenza: A Double Threat

Stabilizing Virus with Albumin to Improve Yield

T Regulatory Cells, The Next T Cell Frontier?

Transferrin: An Iron Transport Protein – Recombinant Human Transferrin in Cell Culture Media

Universal Vaccine Against Seasonal Influenza Steps Closer to Reality with the Results of FluGen Phase 2 Clinical Trial

Using Recombinant Transferrin in the Expansion of Hematopoietic Stem Cells

Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media

Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems

Interviews

Revolutionizing T Cell Immunotherapies

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Accurate nanoelectrode recording of human pluripotent cell-derived cardiomyocytes for assaying drugs and modeling disease

Formulation and Production of Serum-Free OptiVERO Media

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Exbumin Provides Improved Performance and Stability in Vaccine Development

Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin (Cellastim™)

OptiPEAK HEK 293t – InVitria/Pall Biotech iCELLis Poster

Poster 2021: Application of Biomass Probe with Chemically Defined Media in iCELLis

Poster 2021: Lentiviral Vector Production in a Chemically Defined, Blood-Free and Serum-Free Medium

Product Brochures

2020 Product Catalog

2021 Product Catalog

ITSE AF – Brochure

ITSE Animal-Free Brochure

Lysobac – Brochure – E.Coli Lysis

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

ITSE+A – Specifications

OptiPEAK HEK293t – Product Specifications

Cellastim S – Product Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Lysobac – Safety Data Sheet

Lysosure – Safety Data Sheet

Optibumin – Safety Data Sheet

OptiPEAK HEK293t – Safety Data Sheet

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Lysobac – Guidelines for Use

Optiferrin – Guidelines for Use

OptiVERO – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Enhancement of Transient Transfection with Serum-Free and Blood-Free Transferrin

Expansion of Adherent HEK293t Cells in Flasks in Chemically Defined Cell Culture Media